HK40128362A - Metap2 inhibitors for the treatment of pulmonary fibrosis - Google Patents

Metap2 inhibitors for the treatment of pulmonary fibrosis

Info

Publication number
HK40128362A
HK40128362A HK62025116706.5A HK62025116706A HK40128362A HK 40128362 A HK40128362 A HK 40128362A HK 62025116706 A HK62025116706 A HK 62025116706A HK 40128362 A HK40128362 A HK 40128362A
Authority
HK
Hong Kong
Prior art keywords
treatment
pulmonary fibrosis
metap2 inhibitors
metap2
inhibitors
Prior art date
Application number
HK62025116706.5A
Other languages
Chinese (zh)
Inventor
Peter Cornelius
Bradley J. CARVER
Sebastien Labbe
James Shanahan
Original Assignee
Syndevrx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syndevrx, Inc. filed Critical Syndevrx, Inc.
Publication of HK40128362A publication Critical patent/HK40128362A/en

Links

HK62025116706.5A 2022-08-10 2023-08-10 Metap2 inhibitors for the treatment of pulmonary fibrosis HK40128362A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263396836P 2022-08-10
US202263405973P 2022-09-13

Publications (1)

Publication Number Publication Date
HK40128362A true HK40128362A (en) 2026-02-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP3982949A4 (en) Inhibitors of sarm1
CA3296838A1 (en) Capsid inhibitors for the treatment of hiv
EP4028013A4 (en) Inhibitors of sarm1
EP3917516A4 (en) Compounds and methods for the treatment of cystic fibrosis
HK40128362A (en) Metap2 inhibitors for the treatment of pulmonary fibrosis
CA3264343A1 (en) Metap2 inhibitors for the treatment of pulmonary fibrosis
CA3277368A1 (en) Phosphoglicerate dehydrogenase inhibitors for the treatment of fibrosis
CA3277401A1 (en) Phosphoglicerate dehydrogenase inhibitors for the treatment of fibrosis
EP4069216A4 (en) Compounds and methods for the treatment of cystic fibrosis
HK40115372A (en) Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis
HK40091278A (en) Methods of treating pulmonary fibrosis
EP3960171A4 (en) Use of adam9 inhibitor as immunomodulator
AU2020901743A0 (en) Methods of treating pulmonary fibrosis
CA3289747A1 (en) Methods of treating pulmonary fibrosis
AU2023901558A0 (en) Methods of treating pulmonary fibrosis
HK40099578A (en) Methods of treating fibrosis
CA3283855A1 (en) Methods of treating fibrosis
HK40109702A (en) Protease inhibitors for the treatment of coronavirus infections
HK40119787A (en) Methods of treating fibrosis
CA3293703A1 (en) Methods for treatment of pulmonary hypertension
CA3289184A1 (en) Heteroarylindole inhibitors of apol-1
AU2023901140A0 (en) Inhibition of coronavirus
HK40117134A (en) Treprostinil for the treatment of pulmonary hypertension
CA3280853A1 (en) Inhibitors of synaptogyrin-3 expression
HK40068813A (en) Compositions and methods for treatment of cystic fibrosis